Cargando…

A metabolic biomarker predicts Parkinson’s disease at the early stages in patients and animal models

BACKGROUND: Care management of Parkinson’s disease (PD) patients currently remains symptomatic, mainly because diagnosis relying on the expression of the cardinal motor symptoms is made too late. Earlier detection of PD therefore represents a key step for developing therapies able to delay or slow d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mallet, David, Dufourd, Thibault, Decourt, Mélina, Carcenac, Carole, Bossù, Paola, Verlin, Laure, Fernagut, Pierre-Olivier, Benoit-Marand, Marianne, Spalletta, Gianfranco, Barbier, Emmanuel L., Carnicella, Sebastien, Sgambato, Véronique, Fauvelle, Florence, Boulet, Sabrina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Clinical Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843749/ https://www.ncbi.nlm.nih.gov/pubmed/34914634 http://dx.doi.org/10.1172/JCI146400

Ejemplares similares

Hypodopaminergic state of the nigrostriatal pathway drives compulsive alcohol use
por: Goutaudier, Raphaël, et al.
Publicado: (2022)

Plasma or serum? A qualitative study on rodents and humans using high-throughput microRNA sequencing for circulating biomarkers
por: Dufourd, Thibault, et al.
Publicado: (2019)

Neuropsychiatric and Cognitive Deficits in Parkinson’s Disease and Their Modeling in Rodents
por: Decourt, Mélina, et al.
Publicado: (2021)

Premorbid performances determine the deleterious effects of nigrostriatal degeneration and pramipexole on behavioural flexibility
por: Decourt, Mélina, et al.
Publicado: (2023)

Assessment of Repetitive and Compulsive Behaviors Induced by Pramipexole in Rats: Effect of Alpha-Synuclein-Induced Nigrostriatal Degeneration
por: Decourt, Mélina, et al.
Publicado: (2022)

Implication of dorsostriatal D3 receptors in motivational processes: a potential target for neuropsychiatric symptoms in Parkinson’s disease
por: Favier, Mathieu, et al.
Publicado: (2017)

Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats
por: Goutaudier, Raphaël, et al.
Publicado: (2020)

DREADDs: The Power of the Lock, the Weakness of the Key. Favoring the Pursuit of Specific Conditions Rather than Specific Ligands
por: Goutaudier, Raphaël, et al.
Publicado: (2019)

Nigrostriatal Dopaminergic Denervation Does Not Promote Impulsive Choice in the Rat: Implication for Impulse Control Disorders in Parkinson’s Disease
por: Magnard, Robin, et al.
Publicado: (2018)

Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits
por: Carnicella, S, et al.
Publicado: (2014)

What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?
por: Magnard, R, et al.
Publicado: (2016)

Dopamine control of pyramidal neuron activity in the primary motor cortex via D2 receptors
por: Vitrac, Clément, et al.
Publicado: (2014)

High-frequency stimulation of the subthalamic nucleus modifies the expression of vesicular glutamate transporters in basal ganglia in a rat model of Parkinson’s disease
por: Favier, Mathieu, et al.
Publicado: (2013)

Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases
por: Bossù, Paola, et al.
Publicado: (2015)

Implication of Aging Related Chronic Neuroinflammation on COVID-19 Pandemic
por: Bossù, Paola, et al.
Publicado: (2020)

High serum levels of transforming growth factor β1 are associated with increased cortical thickness in cingulate and right frontal areas in healthy subjects
por: Piras, Fabrizio, et al.
Publicado: (2012)

Monoaminergic Modulation of Motor Cortex Function
por: Vitrac, Clément, et al.
Publicado: (2017)

Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia
por: Palladino, Ilaria, et al.
Publicado: (2012)

Left hippocampus–amygdala complex macro- and microstructural variation is associated with BDNF plasma levels in healthy elderly individuals
por: Manna, Antonietta, et al.
Publicado: (2015)

Better Outcomes with Intranigral versus Intrastriatal Cell Transplantation: Relevance for Parkinson’s Disease
por: Droguerre, Marine, et al.
Publicado: (2022)

Myeloid dendritic cells are decreased in peripheral blood of Alzheimer’s disease patients in association with disease progression and severity of depressive symptoms
por: Ciaramella, Antonio, et al.
Publicado: (2016)

IL-33 and IL-10 Serum Levels Increase in MCI Patients Following Homotaurine Treatment
por: Toppi, Elisa, et al.
Publicado: (2022)

Hippocampal volume and depressive symptoms are linked to serum IL-18 in schizophrenia
por: Bossù, Paola, et al.
Publicado: (2015)

Brain microstructural changes and cognitive correlates in patients with pure obsessive compulsive disorder
por: Spalletta, Gianfranco, et al.
Publicado: (2014)

Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
por: Dujardin, Kathy, et al.
Publicado: (2020)

Cortical Grey Matter and Subcortical White Matter Brain Microstructural Changes in Schizophrenia Are Localised and Age Independent: A Case-Control Diffusion Tensor Imaging Study
por: Chiapponi, Chiara, et al.
Publicado: (2013)

Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson’s Disease and Is Associated with Motor Symptom Severity
por: Ciaramella, Antonio, et al.
Publicado: (2013)

Elevated plasma ceramide levels in post-menopausal women: a cross-sectional study
por: Vozella, Valentina, et al.
Publicado: (2019)

Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients
por: Bossù, Paola, et al.
Publicado: (2011)

Polygenic risk and hazard scores for Alzheimer's disease prediction
por: Leonenko, Ganna, et al.
Publicado: (2019)

Metastable States of Multiscale Brain Networks Are Keys to Crack the Timing Problem
por: Gili, Tommaso, et al.
Publicado: (2018)

Editorial: Insights in Aging Psychiatry: 2021
por: Spalletta, Gianfranco, et al.
Publicado: (2022)

Editorial: Rising stars in aging psychiatry: 2022
por: Spalletta, Gianfranco, et al.
Publicado: (2022)

Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson’s Disease
por: Duperrier, Sandra, et al.
Publicado: (2022)

Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson’s Disease?
por: Houeto, Jean-Luc, et al.
Publicado: (2016)

Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment
por: Bossù, Paola, et al.
Publicado: (2018)

Brain Functional Effects of Psychopharmacological Treatments in Schizophrenia: A Network-based Functional Perspective Beyond Neurotransmitter Systems
por: De Rossi, Pietro, et al.
Publicado: (2015)

Editorial: Non-Dopaminergic Systems in Parkinson’s Disease
por: Miguelez, Cristina, et al.
Publicado: (2020)

Mapping Chemical Elements and Iron Oxidation States in the Substantia Nigra of 6-Hydroxydopamine Lesioned Rats Using Correlative Immunohistochemistry With Proton and Synchrotron Micro-Analysis
por: Carmona, Asuncion, et al.
Publicado: (2019)

Gender specific decrease of a set of circulating N-acylphosphatidyl ethanolamines (NAPEs) in the plasma of Parkinson’s disease patients
por: Hamid, Zeeshan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_78d0rfr0npaf07ofd7vok0ebru